Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world Study

Conditions: Breast Cancer Interventions: Other: data collection Sponsors: Regina Elena Cancer Institute Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials